CA2632992A1 - Biosensors and methods for making and using them - Google Patents

Biosensors and methods for making and using them Download PDF

Info

Publication number: CA2632992A1
Authority: CA; Canada
Prior art keywords: layer; analyte; sensor; glucose; protein
Prior art date: 2005-12-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002632992A

Other languages

English (en)

French (fr)

Inventor

Rajiv Shah

Gopikrishnan Soundararajan

Rebecca K. Gottlieb

Udo Hoss

Eric A. Grovender

Shaun Pendo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Medtronic Minimed Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-13

Filing date

2006-12-12

Publication date

2007-06-21

2006-12-12 Application filed by Individual filed Critical Individual

2007-06-21 Publication of CA2632992A1 publication Critical patent/CA2632992A1/en

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 215
239000012491 analyte Substances 0.000 claims abstract description 509
239000012528 membrane Substances 0.000 claims abstract description 160
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 158
239000008103 glucose Substances 0.000 claims abstract description 158
239000000203 mixture Substances 0.000 claims abstract description 144
108010015776 Glucose oxidase Proteins 0.000 claims abstract description 134
235000019420 glucose oxidase Nutrition 0.000 claims abstract description 133
239000004366 Glucose oxidase Substances 0.000 claims abstract description 128
229940116332 glucose oxidase Drugs 0.000 claims abstract description 128
239000010410 layer Substances 0.000 claims description 790
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 161
102000004190 Enzymes Human genes 0.000 claims description 159
108090000790 Enzymes Proteins 0.000 claims description 159
229940088598 enzyme Drugs 0.000 claims description 159
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 147
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 138
229920000642 polymer Polymers 0.000 claims description 116
102000004169 proteins and genes Human genes 0.000 claims description 116
108090000623 proteins and genes Proteins 0.000 claims description 116
239000011148 porous material Substances 0.000 claims description 105
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 95
229910052760 oxygen Inorganic materials 0.000 claims description 95
239000001301 oxygen Substances 0.000 claims description 95
239000000758 substrate Substances 0.000 claims description 95
239000011159 matrix material Substances 0.000 claims description 77
230000008569 process Effects 0.000 claims description 76
230000001737 promoting effect Effects 0.000 claims description 53
229910052751 metal Inorganic materials 0.000 claims description 47
239000002184 metal Substances 0.000 claims description 47
229920002120 photoresistant polymer Polymers 0.000 claims description 45
238000004519 manufacturing process Methods 0.000 claims description 36
241000124008 Mammalia Species 0.000 claims description 33
230000006870 function Effects 0.000 claims description 32
238000009792 diffusion process Methods 0.000 claims description 29
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 27
238000006243 chemical reaction Methods 0.000 claims description 26
102000014914 Carrier Proteins Human genes 0.000 claims description 25
108010078791 Carrier Proteins Proteins 0.000 claims description 25
239000002245 particle Substances 0.000 claims description 24
150000001875 compounds Chemical class 0.000 claims description 23
239000003431 cross linking reagent Substances 0.000 claims description 22
239000002904 solvent Substances 0.000 claims description 21
239000000919 ceramic Substances 0.000 claims description 16
238000002513 implantation Methods 0.000 claims description 16
230000004075 alteration Effects 0.000 claims description 15
150000001412 amines Chemical class 0.000 claims description 15
239000011247 coating layer Substances 0.000 claims description 15
238000004132 cross linking Methods 0.000 claims description 15
229920001477 hydrophilic polymer Polymers 0.000 claims description 15
108010073450 Lactate 2-monooxygenase Proteins 0.000 claims description 14
229920000249 biocompatible polymer Polymers 0.000 claims description 14
239000000017 hydrogel Substances 0.000 claims description 14
102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 13
239000004020 conductor Substances 0.000 claims description 12
108010093096 Immobilized Enzymes Proteins 0.000 claims description 11
230000000269 nucleophilic effect Effects 0.000 claims description 11
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
239000012790 adhesive layer Substances 0.000 claims description 10
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
238000000206 photolithography Methods 0.000 claims description 10
125000003396 thiol group Chemical group [H]S* 0.000 claims description 9
102000005548 Hexokinase Human genes 0.000 claims description 8
108700040460 Hexokinases Proteins 0.000 claims description 8
108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 8
230000003100 immobilizing effect Effects 0.000 claims description 8
239000013528 metallic particle Substances 0.000 claims description 8
238000007639 printing Methods 0.000 claims description 8
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 7
238000011161 development Methods 0.000 claims description 7
238000001035 drying Methods 0.000 claims description 7
108060003951 Immunoglobulin Proteins 0.000 claims description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
102000018358 immunoglobulin Human genes 0.000 claims description 6
229940072221 immunoglobulins Drugs 0.000 claims description 6
238000009713 electroplating Methods 0.000 claims description 4
230000036571 hydration Effects 0.000 claims description 4
238000006703 hydration reaction Methods 0.000 claims description 4
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 3
238000007344 nucleophilic reaction Methods 0.000 claims description 3
239000000843 powder Substances 0.000 claims description 3
230000009471 action Effects 0.000 claims description 2
229920001400 block copolymer Polymers 0.000 claims description 2
238000010304 firing Methods 0.000 claims description 2
238000009736 wetting Methods 0.000 claims description 2
125000003700 epoxy group Chemical group 0.000 claims 3
238000000576 coating method Methods 0.000 abstract description 70
239000000470 constituent Substances 0.000 description 140
235000018102 proteins Nutrition 0.000 description 99
239000000463 material Substances 0.000 description 93
235000013870 dimethyl polysiloxane Nutrition 0.000 description 86
239000004205 dimethyl polysiloxane Substances 0.000 description 85
-1 Kodak AQ) Chemical class 0.000 description 46
238000013461 design Methods 0.000 description 45
239000011248 coating agent Substances 0.000 description 31
230000000670 limiting effect Effects 0.000 description 26
238000004528 spin coating Methods 0.000 description 26
102000009027 Albumins Human genes 0.000 description 24
108010088751 Albumins Proteins 0.000 description 24
229920001577 copolymer Polymers 0.000 description 24
239000002318 adhesion promoter Substances 0.000 description 22
238000004070 electrodeposition Methods 0.000 description 22
239000000126 substance Substances 0.000 description 22
238000006116 polymerization reaction Methods 0.000 description 21
239000000243 solution Substances 0.000 description 21
239000000178 monomer Substances 0.000 description 18
229910000077 silane Inorganic materials 0.000 description 18
229910001868 water Inorganic materials 0.000 description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
239000004642 Polyimide Substances 0.000 description 15
230000008901 benefit Effects 0.000 description 15
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 15
229920001721 polyimide Polymers 0.000 description 15
230000008859 change Effects 0.000 description 14
150000002118 epoxides Chemical group 0.000 description 13
239000007788 liquid Substances 0.000 description 13
238000007920 subcutaneous administration Methods 0.000 description 13
239000008280 blood Substances 0.000 description 12
150000002978 peroxides Chemical class 0.000 description 12
229920001296 polysiloxane Polymers 0.000 description 12
108091003079 Bovine Serum Albumin Proteins 0.000 description 11
210000004369 blood Anatomy 0.000 description 11
229940098773 bovine serum albumin Drugs 0.000 description 11
230000002255 enzymatic effect Effects 0.000 description 11
238000012544 monitoring process Methods 0.000 description 11
230000004044 response Effects 0.000 description 11
239000010409 thin film Substances 0.000 description 11
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 10
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 10
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
239000010408 film Substances 0.000 description 10
150000002739 metals Chemical class 0.000 description 10
108091006905 Human Serum Albumin Proteins 0.000 description 9
102000008100 Human Serum Albumin Human genes 0.000 description 9
229940079593 drug Drugs 0.000 description 9
239000003814 drug Substances 0.000 description 9
239000011521 glass Substances 0.000 description 9
108090000765 processed proteins & peptides Proteins 0.000 description 9
230000008961 swelling Effects 0.000 description 9
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 8
238000001802 infusion Methods 0.000 description 8
229920001184 polypeptide Polymers 0.000 description 8
102000004196 processed proteins & peptides Human genes 0.000 description 8
239000000047 product Substances 0.000 description 8
229910052709 silver Inorganic materials 0.000 description 8
239000004332 silver Substances 0.000 description 8
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
239000000427 antigen Substances 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
239000003153 chemical reaction reagent Substances 0.000 description 7
206010012601 diabetes mellitus Diseases 0.000 description 7
239000012530 fluid Substances 0.000 description 7
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
229910052737 gold Inorganic materials 0.000 description 7
239000010931 gold Substances 0.000 description 7
238000002955 isolation Methods 0.000 description 7
230000035699 permeability Effects 0.000 description 7
229920002635 polyurethane Polymers 0.000 description 7
239000004814 polyurethane Substances 0.000 description 7
239000011241 protective layer Substances 0.000 description 7
230000035945 sensitivity Effects 0.000 description 7
229910052710 silicon Inorganic materials 0.000 description 7
239000010703 silicon Substances 0.000 description 7
241000894007 species Species 0.000 description 7
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
229920002301 cellulose acetate Polymers 0.000 description 6
ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 6
239000007789 gas Substances 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
230000001965 increasing effect Effects 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
230000007774 longterm Effects 0.000 description 6
238000005259 measurement Methods 0.000 description 6
238000007254 oxidation reaction Methods 0.000 description 6
230000010287 polarization Effects 0.000 description 6
238000012545 processing Methods 0.000 description 6
230000001681 protective effect Effects 0.000 description 6
238000004064 recycling Methods 0.000 description 6
150000004756 silanes Chemical class 0.000 description 6
238000005507 spraying Methods 0.000 description 6
230000002792 vascular Effects 0.000 description 6
229920002554 vinyl polymer Polymers 0.000 description 6
108010035532 Collagen Proteins 0.000 description 5
102000008186 Collagen Human genes 0.000 description 5
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 5
238000003556 assay Methods 0.000 description 5
229910052799 carbon Inorganic materials 0.000 description 5
229920001436 collagen Polymers 0.000 description 5
239000002131 composite material Substances 0.000 description 5
230000002596 correlated effect Effects 0.000 description 5
238000001514 detection method Methods 0.000 description 5
KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 5
238000005530 etching Methods 0.000 description 5
210000003722 extracellular fluid Anatomy 0.000 description 5
125000000524 functional group Chemical group 0.000 description 5
239000003960 organic solvent Substances 0.000 description 5
230000003647 oxidation Effects 0.000 description 5
229910052697 platinum Inorganic materials 0.000 description 5
229920001223 polyethylene glycol Polymers 0.000 description 5
239000003361 porogen Substances 0.000 description 5
235000012431 wafers Nutrition 0.000 description 5
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
108010088350 Lactate Dehydrogenase 5 Proteins 0.000 description 4
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
150000001252 acrylic acid derivatives Chemical class 0.000 description 4
125000003545 alkoxy group Chemical group 0.000 description 4
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000013060 biological fluid Substances 0.000 description 4
238000005266 casting Methods 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
229910052802 copper Inorganic materials 0.000 description 4
239000010949 copper Substances 0.000 description 4
238000005520 cutting process Methods 0.000 description 4
230000007423 decrease Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
239000003999 initiator Substances 0.000 description 4
238000007641 inkjet printing Methods 0.000 description 4
230000003993 interaction Effects 0.000 description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
150000002734 metacrylic acid derivatives Chemical class 0.000 description 4
238000000465 moulding Methods 0.000 description 4
231100000252 nontoxic Toxicity 0.000 description 4
230000003000 nontoxic effect Effects 0.000 description 4
238000000059 patterning Methods 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
239000004033 plastic Substances 0.000 description 4
238000002459 porosimetry Methods 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000027756 respiratory electron transport chain Effects 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
229910000679 solder Inorganic materials 0.000 description 4
238000012546 transfer Methods 0.000 description 4
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
229920000557 Nafion® Polymers 0.000 description 3
229920002396 Polyurea Polymers 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
125000002947 alkylene group Chemical group 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
238000005229 chemical vapour deposition Methods 0.000 description 3
230000008878 coupling Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
238000000151 deposition Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000006911 enzymatic reaction Methods 0.000 description 3
238000011049 filling Methods 0.000 description 3
239000011888 foil Substances 0.000 description 3
229960003681 gluconolactone Drugs 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
238000003698 laser cutting Methods 0.000 description 3
239000011344 liquid material Substances 0.000 description 3
230000000873 masking effect Effects 0.000 description 3
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
229910052753 mercury Inorganic materials 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
229920000307 polymer substrate Polymers 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
229920002379 silicone rubber Polymers 0.000 description 3
239000004945 silicone rubber Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000009870 specific binding Effects 0.000 description 3
239000007921 spray Substances 0.000 description 3
238000004544 sputter deposition Methods 0.000 description 3
229910052719 titanium Inorganic materials 0.000 description 3
239000010936 titanium Substances 0.000 description 3
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
HNLITPNLXYBFGZ-UHFFFAOYSA-N CC1=CC=C(O)C(O[SiH2]C=2C(=CC=CC=2)O)=C1C Chemical compound CC1=CC=C(O)C(O[SiH2]C=2C(=CC=CC=2)O)=C1C HNLITPNLXYBFGZ-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
239000004971 Cross linker Substances 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
239000004593 Epoxy Substances 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
229920001730 Moisture cure polyurethane Polymers 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
229910052581 Si3N4 Inorganic materials 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
229910021607 Silver chloride Inorganic materials 0.000 description 2
101710172711 Structural protein Proteins 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
230000000975 bioactive effect Effects 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
239000003990 capacitor Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
229910010293 ceramic material Inorganic materials 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
238000013375 chromatographic separation Methods 0.000 description 2
ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
230000009849 deactivation Effects 0.000 description 2
230000006735 deficit Effects 0.000 description 2
230000032798 delamination Effects 0.000 description 2
230000008021 deposition Effects 0.000 description 2
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
238000009826 distribution Methods 0.000 description 2
238000005553 drilling Methods 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000006260 foam Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
102000034238 globular proteins Human genes 0.000 description 2
108091005896 globular proteins Proteins 0.000 description 2
150000002303 glucose derivatives Chemical class 0.000 description 2
125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
238000013007 heat curing Methods 0.000 description 2
150000004678 hydrides Chemical class 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 2
235000014655 lactic acid Nutrition 0.000 description 2
239000004310 lactic acid Substances 0.000 description 2
238000000608 laser ablation Methods 0.000 description 2
239000003446 ligand Substances 0.000 description 2
238000007726 management method Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
239000012982 microporous membrane Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012806 monitoring device Methods 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
238000009832 plasma treatment Methods 0.000 description 2
238000007747 plating Methods 0.000 description 2
229920006393 polyether sulfone Polymers 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011591 potassium Substances 0.000 description 2
230000005855 radiation Effects 0.000 description 2
229920013730 reactive polymer Polymers 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 2
238000000926 separation method Methods 0.000 description 2
150000004819 silanols Chemical class 0.000 description 2
HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
150000003440 styrenes Chemical class 0.000 description 2
150000003460 sulfonic acids Chemical class 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
229920001059 synthetic polymer Polymers 0.000 description 2
238000012360 testing method Methods 0.000 description 2
229940116269 uric acid Drugs 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
229940117958 vinyl acetate Drugs 0.000 description 2
UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
QLLUAUADIMPKIH-UHFFFAOYSA-N 1,2-bis(ethenyl)naphthalene Chemical compound C1=CC=CC2=C(C=C)C(C=C)=CC=C21 QLLUAUADIMPKIH-UHFFFAOYSA-N 0.000 description 1
OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 description 1
FCMUPMSEVHVOSE-UHFFFAOYSA-N 2,3-bis(ethenyl)pyridine Chemical compound C=CC1=CC=CN=C1C=C FCMUPMSEVHVOSE-UHFFFAOYSA-N 0.000 description 1
CCTFAOUOYLVUFG-UHFFFAOYSA-N 2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide Chemical compound NC(=N)C(C)(C)N=NC(C)(C)C(N)=N CCTFAOUOYLVUFG-UHFFFAOYSA-N 0.000 description 1
UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
CXURGFRDGROIKG-UHFFFAOYSA-N 3,3-bis(chloromethyl)oxetane Chemical compound ClCC1(CCl)COC1 CXURGFRDGROIKG-UHFFFAOYSA-N 0.000 description 1
ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229910000838 Al alloy Inorganic materials 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
102000011632 Caseins Human genes 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
229920000106 Liquid crystal polymer Polymers 0.000 description 1
239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
229910052779 Neodymium Inorganic materials 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
150000003926 acrylamides Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
239000000010 aprotic solvent Substances 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000019400 benzoyl peroxide Nutrition 0.000 description 1
230000027455 binding Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
238000012925 biological evaluation Methods 0.000 description 1
239000012620 biological material Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000008364 bulk solution Substances 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
229940021722 caseins Drugs 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
210000003756 cervix mucus Anatomy 0.000 description 1
150000004770 chalcogenides Chemical class 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008602 contraction Effects 0.000 description 1
239000002872 contrast media Substances 0.000 description 1
239000005289 controlled pore glass Substances 0.000 description 1
238000005336 cracking Methods 0.000 description 1
229920006037 cross link polymer Polymers 0.000 description 1
229960003280 cupric chloride Drugs 0.000 description 1
238000001723 curing Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000002484 cyclic voltammetry Methods 0.000 description 1
YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical compound NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000005137 deposition process Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
125000004386 diacrylate group Chemical group 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
229910003460 diamond Inorganic materials 0.000 description 1
239000010432 diamond Substances 0.000 description 1
AYOHIQLKSOJJQH-UHFFFAOYSA-N dibutyltin Chemical compound CCCC[Sn]CCCC AYOHIQLKSOJJQH-UHFFFAOYSA-N 0.000 description 1
229940117389 dichlorobenzene Drugs 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
150000004683 dihydrates Chemical class 0.000 description 1
125000005442 diisocyanate group Chemical group 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
229910001882 dioxygen Inorganic materials 0.000 description 1
238000003618 dip coating Methods 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
210000000959 ear middle Anatomy 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
238000003487 electrochemical reaction Methods 0.000 description 1
238000007772 electroless plating Methods 0.000 description 1
238000006056 electrooxidation reaction Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
229940052303 ethers for general anesthesia Drugs 0.000 description 1
238000002618 extracorporeal membrane oxygenation Methods 0.000 description 1
239000003925 fat Substances 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
230000005669 field effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000004833 fish glue Substances 0.000 description 1
NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
238000013012 foaming technology Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000007306 functionalization reaction Methods 0.000 description 1
229910052733 gallium Inorganic materials 0.000 description 1
108010074605 gamma-Globulins Proteins 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
229910021397 glassy carbon Inorganic materials 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
235000012209 glucono delta-lactone Nutrition 0.000 description 1
239000003292 glue Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
239000010439 graphite Substances 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
108010018734 hexose oxidase Proteins 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000012623 in vivo measurement Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000009413 insulation Methods 0.000 description 1
229920000554 ionomer Polymers 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229910052741 iridium Inorganic materials 0.000 description 1
GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
239000002085 irritant Substances 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
229940047889 isobutyramide Drugs 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
150000002596 lactones Chemical group 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
239000012035 limiting reagent Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
239000008258 liquid foam Substances 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000004880 lymph fluid Anatomy 0.000 description 1
238000013178 mathematical model Methods 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
239000007769 metal material Substances 0.000 description 1
239000006262 metallic foam Substances 0.000 description 1
238000001465 metallisation Methods 0.000 description 1
FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical class CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
238000003801 milling Methods 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
ORQBXQOJMQIAOY-UHFFFAOYSA-N nobelium Chemical compound [No] ORQBXQOJMQIAOY-UHFFFAOYSA-N 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
229910052762 osmium Inorganic materials 0.000 description 1
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
239000008188 pellet Substances 0.000 description 1
WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
239000012466 permeate Substances 0.000 description 1
238000005240 physical vapour deposition Methods 0.000 description 1
210000004910 pleural fluid Anatomy 0.000 description 1
229920000352 poly(styrene-co-divinylbenzene) Polymers 0.000 description 1
239000013047 polymeric layer Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 1
YPVDWEHVCUBACK-UHFFFAOYSA-N propoxycarbonyloxy propyl carbonate Chemical compound CCCOC(=O)OOC(=O)OCCC YPVDWEHVCUBACK-UHFFFAOYSA-N 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
238000010526 radical polymerization reaction Methods 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000006479 redox reaction Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
229910052703 rhodium Inorganic materials 0.000 description 1
239000010948 rhodium Substances 0.000 description 1
MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
229910052594 sapphire Inorganic materials 0.000 description 1
239000010980 sapphire Substances 0.000 description 1
238000007650 screen-printing Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000013545 self-assembled monolayer Substances 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
208000013223 septicemia Diseases 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
239000002356 single layer Substances 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
238000002174 soft lithography Methods 0.000 description 1
239000008259 solid foam Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
230000005328 spin glass Effects 0.000 description 1
238000009987 spinning Methods 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
229910052712 strontium Inorganic materials 0.000 description 1
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
108020001568 subdomains Proteins 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
238000010345 tape casting Methods 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
229910052723 transition metal Inorganic materials 0.000 description 1
150000003624 transition metals Chemical class 0.000 description 1
230000032258 transport Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229920001567 vinyl ester resin Polymers 0.000 description 1
229960000834 vinyl ether Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000011800 void material Substances 0.000 description 1
238000004832 voltammetry Methods 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Emergency Medicine (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Steroid Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA002632992A 2005-12-13 2006-12-12 Biosensors and methods for making and using them Abandoned CA2632992A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/301,512		2005-12-13
US11/301,512 US7813780B2 (en)	2005-12-13	2005-12-13	Biosensors and methods for making and using them
PCT/US2006/047271 WO2007070486A2 (en)	2005-12-13	2006-12-12	Biosensors and methods for making and using them

Publications (1)

Publication Number	Publication Date
CA2632992A1 true CA2632992A1 (en)	2007-06-21

Family

ID=38008026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002632992A Abandoned CA2632992A1 (en)	2005-12-13	2006-12-12	Biosensors and methods for making and using them

Country Status (8)

Country	Link
US (3)	US7813780B2 (de)
EP (1)	EP1969359B1 (de)
JP (1)	JP5052525B2 (de)
AT (1)	ATE473433T1 (de)
CA (1)	CA2632992A1 (de)
DE (1)	DE602006015357D1 (de)
DK (1)	DK1969359T3 (de)
WO (1)	WO2007070486A2 (de)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8527026B2 (en)	1997-03-04	2013-09-03	Dexcom, Inc.	Device and method for determining analyte levels
US6001067A (en)	1997-03-04	1999-12-14	Shults; Mark C.	Device and method for determining analyte levels
US20030032874A1 (en)	2001-07-27	2003-02-13	Dexcom, Inc.	Sensor head for use with implantable devices
US7828728B2 (en)	2003-07-25	2010-11-09	Dexcom, Inc.	Analyte sensor
US8364229B2 (en)	2003-07-25	2013-01-29	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7613491B2 (en)	2002-05-22	2009-11-03	Dexcom, Inc.	Silicone based membranes for use in implantable glucose sensors
US20070227907A1 (en)	2006-04-04	2007-10-04	Rajiv Shah	Methods and materials for controlling the electrochemistry of analyte sensors
US9492111B2 (en) *	2002-04-22	2016-11-15	Medtronic Minimed, Inc.	Methods and materials for stabilizing analyte sensors
US7226978B2 (en)	2002-05-22	2007-06-05	Dexcom, Inc.	Techniques to improve polyurethane membranes for implantable glucose sensors
US9763609B2 (en)	2003-07-25	2017-09-19	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
JP4708342B2 (ja)	2003-07-25	2011-06-22	デックスコム・インコーポレーテッド	埋設可能な装置に用いる酸素増大膜システム
US7761130B2 (en)	2003-07-25	2010-07-20	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
WO2005012873A2 (en)	2003-07-25	2005-02-10	Dexcom, Inc.	Electrode systems for electrochemical sensors
US9135402B2 (en)	2007-12-17	2015-09-15	Dexcom, Inc.	Systems and methods for processing sensor data
US7591801B2 (en)	2004-02-26	2009-09-22	Dexcom, Inc.	Integrated delivery device for continuous glucose sensor
US7920906B2 (en)	2005-03-10	2011-04-05	Dexcom, Inc.	System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en)	2004-07-13	2016-02-02	Dexcom, Inc.	Analyte sensor
EP2239567B1 (de)	2003-12-05	2015-09-02	DexCom, Inc.	Kalibrierverfahren für einen kontinuierlichen Analytsensor
US11633133B2 (en)	2003-12-05	2023-04-25	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US8423114B2 (en)	2006-10-04	2013-04-16	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US7146203B2 (en)	2003-12-18	2006-12-05	Elliot Botvinick	Implantable biosensor and methods of use thereof
US8808228B2 (en)	2004-02-26	2014-08-19	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
US8277713B2 (en)	2004-05-03	2012-10-02	Dexcom, Inc.	Implantable analyte sensor
US8989833B2 (en)	2004-07-13	2015-03-24	Dexcom, Inc.	Transcutaneous analyte sensor
US7857760B2 (en)	2004-07-13	2010-12-28	Dexcom, Inc.	Analyte sensor
WO2006127694A2 (en)	2004-07-13	2006-11-30	Dexcom, Inc.	Analyte sensor
US8133178B2 (en)	2006-02-22	2012-03-13	Dexcom, Inc.	Analyte sensor
US8744546B2 (en)	2005-05-05	2014-06-03	Dexcom, Inc.	Cellulosic-based resistance domain for an analyte sensor
WO2007147475A1 (en) *	2006-06-19	2007-12-27	Roche Diagnostics Gmbh	Amperometric sensor and method for its manufacturing
US9700252B2 (en)	2006-06-19	2017-07-11	Roche Diabetes Care, Inc.	Amperometric sensor and method for its manufacturing
US20200037874A1 (en)	2007-05-18	2020-02-06	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080306434A1 (en)	2007-06-08	2008-12-11	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
US7972866B2 (en) *	2007-06-18	2011-07-05	Nipro Diagnostics, Inc.	Biosensor and ultrasonic method of making a biosensor
US20090024015A1 (en) *	2007-07-17	2009-01-22	Edwards Lifesciences Corporation	Sensing element having an adhesive backing
US9968742B2 (en) *	2007-08-29	2018-05-15	Medtronic Minimed, Inc.	Combined sensor and infusion set using separated sites
US20120046533A1 (en) *	2007-08-29	2012-02-23	Medtronic Minimed, Inc.	Combined sensor and infusion sets
WO2009046161A1 (en) *	2007-10-05	2009-04-09	Bayer Healthcare Llc	Method of defining electrodes using laser-ablation and dielectric material
EP2227132B1 (de)	2007-10-09	2023-03-08	DexCom, Inc.	Integriertes insulin-abgabesystem mit kontinuierlichem glucosesensor
US8417312B2 (en)	2007-10-25	2013-04-09	Dexcom, Inc.	Systems and methods for processing sensor data
CN101835627B (zh) *	2007-10-26	2011-08-03	三菱铅笔株式会社	自动铅笔
US8512731B2 (en) *	2007-11-13	2013-08-20	Medtronic Minimed, Inc.	Antimicrobial coatings for medical devices and methods for making and using them
JP5296805B2 (ja)	2007-12-10	2013-09-25	バイエル・ヘルスケア・エルエルシー	バイオセンサーのための多孔性粒子試薬組成物、装置及び方法
US9839395B2 (en)	2007-12-17	2017-12-12	Dexcom, Inc.	Systems and methods for processing sensor data
US20090275815A1 (en) *	2008-03-21	2009-11-05	Nova Biomedical Corporation	Temperature-compensated in-vivo sensor
US8583204B2 (en)	2008-03-28	2013-11-12	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
US8682408B2 (en)	2008-03-28	2014-03-25	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
US11730407B2 (en)	2008-03-28	2023-08-22	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
JP5131917B2 (ja) *	2008-06-04	2013-01-30	株式会社船井電機新応用技術研究所	酵素センサ
WO2010017119A1 (en) *	2008-08-06	2010-02-11	Reusense, Llc	Reusable analyte sensing system and methods
EP4227675B1 (de)	2008-09-19	2024-12-11	DexCom, Inc.	Partikelhaltige membran und partikelelektrode für analytsensoren
WO2010072861A1 (es) *	2008-12-22	2010-07-01	Universidad De Barcelona	Procedimiento de fabricación de nanocanales
US8394463B1 (en) *	2009-01-23	2013-03-12	Medtronic Minimed, Inc.	Crosslinking compounds at negative pressures and materials made by such methods
CN102438517B (zh) *	2009-02-26	2015-03-25	雅培糖尿病护理公司	改进的分析物传感器及其制造和使用方法
US9517023B2 (en) *	2009-06-01	2016-12-13	Profusa, Inc.	Method and system for directing a localized biological response to an implant
US8828201B2 (en)	2009-07-02	2014-09-09	Dexcom, Inc.	Analyte sensors and methods of manufacturing same
US9351677B2 (en)	2009-07-02	2016-05-31	Dexcom, Inc.	Analyte sensor with increased reference capacity
EP3689237B1 (de)	2009-07-23	2021-05-19	Abbott Diabetes Care, Inc.	Herstellungsverfahren und system zur kontinuierlichen analytmessung
US20110053173A1 (en) *	2009-08-28	2011-03-03	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Game with detection capability
US8810417B2 (en) *	2009-08-28	2014-08-19	The Invention Science Fund I, Llc	Beverage immersate with detection capability
US9024766B2 (en) *	2009-08-28	2015-05-05	The Invention Science Fund, Llc	Beverage containers with detection capability
EP2365329A1 (de) *	2010-03-12	2011-09-14	Hivox Biotek Inc.	Verfahren zur Herstellung eines ebenen Bioteststreifens und entsprechendes Produkt
US10448872B2 (en) *	2010-03-16	2019-10-22	Medtronic Minimed, Inc.	Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
WO2011140193A1 (en) *	2010-05-04	2011-11-10	Massachusetts Institute Of Technology	Implantable dissolved oxygen sensor and methods of use
US10010272B2 (en)	2010-05-27	2018-07-03	Profusa, Inc.	Tissue-integrating electronic apparatus
US9215995B2 (en)	2010-06-23	2015-12-22	Medtronic Minimed, Inc.	Sensor systems having multiple probes and electrode arrays
US9322103B2 (en)	2010-08-06	2016-04-26	Microchips Biotech, Inc.	Biosensor membrane composition, biosensor, and methods for making same
JP5827999B2 (ja)	2010-10-06	2015-12-02	プロフューザ，インコーポレイティド	組織集積センサー
US9084570B2 (en) *	2010-10-08	2015-07-21	Roche Diagnostics Operations, Inc.	Electrochemical sensor having symmetrically distributed analyte sensitive areas
US8663125B2 (en)	2011-03-30	2014-03-04	Sharp Laboratories Of America, Inc.	Dual path noise detection and isolation for acoustic ambulatory respiration monitoring system
US8663124B2 (en)	2011-03-30	2014-03-04	Sharp Laboratories Of America, Inc.	Multistage method and system for estimating respiration parameters from acoustic signal
US9274432B2 (en) *	2011-09-28	2016-03-01	The United States Of America, As Represented By The Secretary Of The Navy	Selective masking by photolithography (SMP) for making electrochemical measurements
KR101394221B1 (ko) *	2011-10-06	2014-05-14	주식회사 인지바이오	한 번의 시료 주입으로 순차적인 반응 조건의 변화가 가능한 멤브레인 센서
US9297781B2 (en) *	2011-10-14	2016-03-29	Samsung Electronics Co, Ltd.	Electrode system and method for calculating character values of solution using the same
EP2834007B1 (de)	2012-04-04	2019-06-26	University of Cincinnati	Vorrichtung und verfahren zur schweissentnahme
GB201211309D0 (en) *	2012-06-26	2012-08-08	Fujifilm Mfg Europe Bv	Process for preparing membranes
US20150216442A1 (en) *	2012-07-24	2015-08-06	Lev Lavy	Multilayer coaxial probe for impedance spatial contrast measurement
US9788765B2 (en)	2012-09-28	2017-10-17	Dexcom, Inc.	Zwitterion surface modifications for continuous sensors
WO2014070383A1 (en) *	2012-10-30	2014-05-08	Edwards Lifesciences Corporation	Analyte sensor and fabrication methods
US9222178B2 (en)	2013-01-22	2015-12-29	GTA, Inc.	Electrolyzer
US8808512B2 (en)	2013-01-22	2014-08-19	GTA, Inc.	Electrolyzer apparatus and method of making it
US20160007893A1 (en) *	2013-02-06	2016-01-14	Loxbridge Research Llp	Systems and methods for early disease detection and real-time disease monitoring
HUE059358T2 (hu) *	2013-03-06	2022-11-28	Hoffmann La Roche	Eljárás egy analit érzékelésére Mn2O3 katalizátorral rendelkezõ szenzor használatával
EP2967457B1 (de) *	2013-03-14	2019-11-27	Becton, Dickinson and Company	Am körper getragener sensor für kontinuierliche glucosemessung
CN113274007B (zh)	2013-03-14	2024-10-18	普罗菲尤萨股份有限公司	用于校正光学信号的方法和装置
US9737250B2 (en)	2013-03-15	2017-08-22	Dexcom, Inc.	Membrane for continuous analyte sensors
US8969134B2 (en) *	2013-05-10	2015-03-03	Intel Corporation	Laser ablation tape for solder interconnect formation
WO2014197786A2 (en)	2013-06-06	2014-12-11	Kintz Gregory J	Apparatus and methods for detecting optical signals from implanted sensors
US9828620B2 (en)	2013-06-28	2017-11-28	Verily Life Sciences Llc	Porous polymeric formulation prepared using monomer
US9750445B2 (en)	2013-06-28	2017-09-05	Verily Life Sciences Llc	Porous polymeric formulation prepared using porogens
US10888244B2 (en)	2013-10-18	2021-01-12	University Of Cincinnati	Sweat sensing with chronological assurance
EP3165154A3 (de)	2013-10-18	2017-07-26	University of Cincinnati	Vorrichtungen für integrierte, wiederholte, verlängerte und/oder zuverlässige schweissstimulation und biosensor
WO2015058064A1 (en) *	2013-10-18	2015-04-23	University Of Cincinnati	Sweat sensing with chronological assurance
US9739746B1 (en)	2013-12-23	2017-08-22	Google Inc.	Analyte sensor incorporating negatively charged moieties
US9855359B2 (en)	2013-12-23	2018-01-02	Verily Life Sciences Llc	Analyte sensors with ethylene oxide immunity
US9834805B2 (en)	2013-12-23	2017-12-05	Verily Life Sciences Llc	Two-layer analyte sensor
US20170095183A1 (en) *	2014-05-28	2017-04-06	University Of Cincinnati	Vertical-flow electronic bio-chemical sensing devices
JP2017522924A (ja)	2014-05-28	2017-08-17	ユニバーシティ・オブ・シンシナティ	センサと汗腺との間で減少した汗体積を備える装置
US11129554B2 (en)	2014-05-28	2021-09-28	University Of Cincinnati	Sweat monitoring and control of drug delivery
EP3148430A4 (de)	2014-05-28	2018-05-16	University of Cincinnati	Fortschrittliche schweisssensorhaftungs-, -versiegelungs- und fluidische strategien
CA2962340A1 (en)	2014-09-22	2016-03-31	University Of Cincinnati	Sweat sensing with analytical assurance
CN111067544B (zh)	2015-02-13	2023-04-07	辛辛那提大学	集成间接汗液刺激和感测的装置
US10864367B2 (en)	2015-02-24	2020-12-15	Elira, Inc.	Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
US10335302B2 (en)	2015-02-24	2019-07-02	Elira, Inc.	Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US10765863B2 (en)	2015-02-24	2020-09-08	Elira, Inc.	Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10376145B2 (en)	2015-02-24	2019-08-13	Elira, Inc.	Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US10118035B2 (en)	2015-02-24	2018-11-06	Elira, Inc.	Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US9956393B2 (en)	2015-02-24	2018-05-01	Elira, Inc.	Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US20220062621A1 (en)	2015-02-24	2022-03-03	Elira, Inc.	Electrical Stimulation-Based Weight Management System
US10383558B2 (en) *	2015-03-06	2019-08-20	Samsung Electronics Co., Ltd.	Device for measuring bio information and method for manufacturing the same
US10646142B2 (en)	2015-06-29	2020-05-12	Eccrine Systems, Inc.	Smart sweat stimulation and sensing devices
KR20180059800A (ko)	2015-09-02	2018-06-05	메트로놈 헬스, 인크.	옵토-효소 분석물 센서를 이용하는 연속 건강 모니터링 시스템 및 방법
WO2017070640A1 (en)	2015-10-23	2017-04-27	Eccrine Systems, Inc.	Devices capable of sample concentration for extended sensing of sweat analytes
CN108430308A (zh)	2015-10-30	2018-08-21	辛辛那提大学	具有电磁屏蔽传感器、互连和电子器件的汗液感测设备
WO2017089380A1 (en) *	2015-11-27	2017-06-01	Radiometer Medical Aps	An outer layer for enzyme sensors
US10674946B2 (en)	2015-12-18	2020-06-09	Eccrine Systems, Inc.	Sweat sensing devices with sensor abrasion protection
KR101757077B1 (ko)	2015-12-28	2017-07-12	한양대학교 에리카산학협력단	전기화학센서, 및 그 제조 방법
AU2016381968B2 (en)	2015-12-30	2020-03-19	Dexcom, Inc.	Biointerface layer for analyte sensors
US20170299538A1 (en) *	2016-04-14	2017-10-19	Verily Life Sciences Llc	Apparatus and methods for providing dual-layer enzymatic sensor
JP6534959B2 (ja) *	2016-04-21	2019-06-26	信越化学工業株式会社	有機膜の形成方法及び半導体装置用基板の製造方法
US11298059B2 (en)	2016-05-13	2022-04-12	PercuSense, Inc.	Analyte sensor
US10471249B2 (en)	2016-06-08	2019-11-12	University Of Cincinnati	Enhanced analyte access through epithelial tissue
US11253190B2 (en)	2016-07-01	2022-02-22	University Of Cincinnati	Devices with reduced microfluidic volume between sensors and sweat glands
WO2018017619A1 (en)	2016-07-19	2018-01-25	Eccrine Systems, Inc.	Sweat conductivity, volumetric sweat rate and galvanic skin response devices and applications
EP3275362B1 (de) *	2016-07-28	2022-12-28	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Vorrichtung zur überwachung eines zustands eines lebewesens
WO2018035091A1 (en)	2016-08-15	2018-02-22	University Of Florida Research Foundation, Inc.	Methods and compositions relating to tunable nanoporous coatings
CN109843372B (zh)	2016-08-19	2023-06-16	辛辛那提大学	长时间汗液刺激
US10736565B2 (en)	2016-10-14	2020-08-11	Eccrine Systems, Inc.	Sweat electrolyte loss monitoring devices
US11331018B2 (en)	2016-12-22	2022-05-17	Profusa, Inc.	System and single-channel biosensor for and method of determining analyte value
CN106773533A (zh) *	2017-02-09	2017-05-31	中国科学院上海微系统与信息技术研究所	一种光刻胶及其应用方法
US12109032B1 (en)	2017-03-11	2024-10-08	Biolinq Incorporated	Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure
US11045142B1 (en)	2017-04-29	2021-06-29	Biolinq, Inc.	Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry
WO2018213570A2 (en)	2017-05-17	2018-11-22	University Of Florida Research Foundation	Methods and sensors for detection
US12599337B1 (en)	2017-08-08	2026-04-14	Biolinq Incorporated	Method and system for confirmation of microneedle-based analyte-selective sensor insertion into viable tissue via electrical interrogation
US11874249B2 (en)	2017-08-23	2024-01-16	Mayo Foundation For Medical Education And Research	Graphite biosensor and circuit structure and method of manufacture
EP3928687B1 (de)	2017-10-24	2024-06-26	Dexcom, Inc.	Tragbare vorrichtung mit vorverbundenem analytsensor
US11331022B2 (en)	2017-10-24	2022-05-17	Dexcom, Inc.	Pre-connected analyte sensors
US10040948B1 (en)	2017-11-21	2018-08-07	Uxn Co., Ltd.	Method of making a colloid and nanoporous layer
US12248123B2 (en)	2017-12-20	2025-03-11	University Of Florida Research Foundation, Inc.	Methods of forming an antireflective layer on a complex substrate and complex substrates having the antireflective layer
WO2019126248A1 (en) *	2017-12-20	2019-06-27	University Of Florida Research Foundation	Methods and sensors for detection
US11705527B2 (en)	2017-12-21	2023-07-18	University Of Florida Research Foundation, Inc.	Substrates having a broadband antireflection layer and methods of forming a broadband antireflection layer
US12258470B2 (en)	2018-02-13	2025-03-25	University Of Florida Research Foundation, Inc.	Chromogenic materials, methods of making chromogenic materials, and methods of use
KR102050952B1 (ko) *	2018-02-20	2019-12-02	고려대학교 산학협력단	부착형 신축성 땀센서
US12076145B2 (en) *	2018-04-19	2024-09-03	Abbott Diabetes Care Inc.	Lactate sensors and associated methods
US11819277B2 (en)	2018-06-20	2023-11-21	University Of Florida Research Foundation, Inc.	Intraocular pressure sensing material, devices, and uses thereof
CN113597549B (zh) *	2019-03-27	2024-07-12	日写株式会社	Mems气体传感器安装体
WO2020220261A1 (en) *	2019-04-30	2020-11-05	Micro Tech Medical (Hangzhou) Co., Ltd.	Biosensors coated with co-polymers and their uses thereof
JP2021525356A (ja) *	2019-04-30	2021-09-24	微泰医療器械（杭州）有限公司ＭｉｃｒｏＴｅｃｈＭｅｄｉｃａｌ（Ｈａｎｇｚｈｏｕ）Ｃｏ．，Ｌｔｄ．	共重合体でコーティングされたバイオセンサーを有するバイオセンサシステムおよびその使用
KR102314267B1 (ko) *	2019-05-31	2021-10-19	비케이전자 주식회사	나노 다공성 실리카 고정 복합체를 포함하는 글루코즈 선택적 투과 불순물 차단층 및 이의 제조 방법
US12385874B2 (en)	2019-08-12	2025-08-12	Trustees Of Tufts College	Modularized field-effect transistor biosensors
TWI895375B (zh) *	2020-03-13	2025-09-01	瑞士商赫孚孟拉羅股份公司	製備工作電極的方法、分析物感測器及其用途，以及測量樣品中之分析物的方法
FI20205422A1 (en) *	2020-04-27	2021-10-28	Aalto Univ Foundation Sr	Test strip for the detection of neutral analytes in a sample
US20220031244A1 (en)	2020-07-29	2022-02-03	Biolinq Inc.	Continuous analyte monitoring system with microneedle array
US11717787B2 (en) *	2021-01-04	2023-08-08	Saudi Arabian Oil Company	High free volume membrane for gas separation
EP4130729A1 (de) *	2021-08-04	2023-02-08	Roche Diabetes Care GmbH	Öffnungsformung in einer membran eines biosensors
EP4326891A1 (de) *	2021-04-19	2024-02-28	W. L. Gore & Associates, Inc.	Elektrochemische analytbiosensoren, zugehörige stoffzusammensetzungen und verfahren zur herstellung und verwendung davon
EP4153276B1 (de)	2021-05-08	2025-12-10	Biolinq Incorporated	Fehlererkennung für eine auf mikronadelarrays basierende kontinuierliche analytüberwachungsvorrichtung
CN113662529A (zh) *	2021-09-24	2021-11-19	西北工业大学	一种监测呼吸的柔性传感器制备方法
EP4658168A2 (de)	2023-02-02	2025-12-10	Biolinq, Inc.	Verfahren zur verbesserten sensorempfindlichkeit eines kontinuierlichen analytüberwachungssystems auf mikronadelbasis
CN115856040A (zh) *	2023-02-07	2023-03-28	博奥生物集团有限公司	一种血糖检测装置

Family Cites Families (130)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2899658A (en)		1959-08-11		Leaf-type electrical resistance strain gage
US2402950A (en)	1943-04-13	1946-07-02	Merlyn M Culver	Molded part and method of forming same
US2519541A (en)	1947-11-08	1950-08-22	Fluid Control Engineering Co	Valve construction
US4034959A (en)	1975-12-24	1977-07-12	Acf Industries, Incorporated	Valve seal retaining means
US4104099A (en)	1977-01-27	1978-08-01	International Telephone And Telegraph Corporation	Method and apparatus for lapping or polishing materials
US4163544A (en)	1977-11-10	1979-08-07	Acf Industries, Incorporated	Two piece composite valve seal ring construction
US4373527B1 (en)	1979-04-27	1995-06-27	Univ Johns Hopkins	Implantable programmable medication infusion system
US4573994A (en)	1979-04-27	1986-03-04	The Johns Hopkins University	Refillable medication infusion apparatus
US4783441A (en)	1979-04-30	1988-11-08	Hoechst Aktiengesellschaft	Aqueous protein solutions stable to denaturation
US4356074A (en)	1980-08-25	1982-10-26	The Yellow Springs Instrument Company, Inc.	Substrate specific galactose oxidase enzyme electrodes
US4373009A (en)	1981-05-18	1983-02-08	International Silicone Corporation	Method of forming a hydrophilic coating on a substrate
US4714234A (en)	1982-09-07	1987-12-22	Greatbatch Enterprises, Inc.	Low power electromagnetic valve
US4568250A (en)	1982-09-07	1986-02-04	Greatbatch Enterprises, Inc.	Low power electromagnetic pump
US4569641A (en)	1982-09-07	1986-02-11	Greatbatch Enterprises, Inc.	Low power electromagnetic pump
US4769013A (en)	1982-09-13	1988-09-06	Hydromer, Inc.	Bio-effecting medical material and device
US4636150A (en)	1983-05-23	1987-01-13	Greatbatch Enterprises, Inc.	Low power electromagnetic pump
US4560375A (en)	1983-06-30	1985-12-24	Pudenz-Schulte Medical Research Corp.	Flow control valve
JPS60173452A (ja)	1984-02-20	1985-09-06	Fuji Electric Corp Res & Dev Ltd	酵素電極用固定化酵素膜の形成方法
US4626244A (en)	1985-02-01	1986-12-02	Consolidated Controls Corporation	Implantable medication infusion device
GB2174007B (en)	1985-03-29	1989-09-06	Molten Corp	Denture base provided with rubber-like resilient lining layer and process for producing the same.
US4656074A (en) *	1985-04-09	1987-04-07	Collins & Aikman Corporation	Extruded closed cell thermoplastic foam
DE3687646T3 (de)	1985-06-21	2001-05-31	Matsushita Electric Industrial Co., Ltd.	Biosensor und dessen herstellung.
GB8521192D0 (en)	1985-08-23	1985-10-02	Courtaulds Plc	Polymeric carrier materials
US4890620A (en)	1985-09-20	1990-01-02	The Regents Of The University Of California	Two-dimensional diffusion glucose substrate sensing electrode
GB8612861D0 (en)	1986-05-27	1986-07-02	Cambridge Life Sciences	Immobilised enzyme biosensors
US5019260A (en)	1986-12-23	1991-05-28	Pall Corporation	Filtration media with low protein adsorbability
DE3852122T2 (de) *	1987-03-12	1995-04-27	Japan Government	Immobilisierung von biofunktionellem material, daraus erzeugtes element und massnahme zu dessen verwendung.
US5352348A (en) *	1987-04-09	1994-10-04	Nova Biomedical Corporation	Method of using enzyme electrode
US4759828A (en)	1987-04-09	1988-07-26	Nova Biomedical Corporation	Glucose electrode and method of determining glucose
US5001009A (en)	1987-09-02	1991-03-19	Sterilization Technical Services, Inc.	Lubricious hydrophilic composite coated on substrates
US4950256A (en)	1988-04-07	1990-08-21	Luther Medical Products, Inc.	Non-thrombogenic intravascular time release catheter
US5196088A (en)	1988-08-05	1993-03-23	Tru Vue, Inc.	Process and apparatus for producing non-glare glass by etching
US5200051A (en)	1988-11-14	1993-04-06	I-Stat Corporation	Wholly microfabricated biosensors and process for the manufacture and use thereof
US5212050A (en)	1988-11-14	1993-05-18	Mier Randall M	Method of forming a permselective layer
US5077210A (en)	1989-01-13	1991-12-31	Eigler Frances S	Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent
EP0397130B1 (de)	1989-05-11	1995-04-19	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Medizinische Anordnung mit hochbiokompatibler Oberfläche und Verfahren zu deren Herstellung
US4958661A (en)	1989-08-08	1990-09-25	The Lee Company	Check valve
US5330911A (en)	1989-09-28	1994-07-19	Board Of Regents, The University Of Texas System	Surfaces having desirable cell adhesive effects
DE69020908T2 (de)	1989-12-15	1996-02-15	Boehringer Mannheim Corp., Indianapolis, Ind.	Redox-vermittlungs-reagenz und biosensor.
EP0433485B1 (de)	1989-12-21	1993-05-19	Siemens Aktiengesellschaft	Anordnung zum transkutanen Ein- oder Nachfüllen von flüssigen Medikamenten in ein implantierbares Medikamentendosiergerät
US5108819A (en)	1990-02-14	1992-04-28	Eli Lilly And Company	Thin film electrical component
US5867399A (en) *	1990-04-06	1999-02-02	Lsi Logic Corporation	System and method for creating and validating structural description of electronic system from higher-level and behavior-oriented description
US5165407A (en)	1990-04-19	1992-11-24	The University Of Kansas	Implantable glucose sensor
DE4018597A1 (de)	1990-06-09	1991-12-12	Draegerwerk Ag	Messelektrode fuer eine elektrochemische gasmesszelle
NL9002764A (nl) *	1990-12-14	1992-07-01	Tno	Elektrode, voorzien van een polymeerbekleding met een daaraan gebonden redox-enzym.
JP3017816B2 (ja)	1991-02-20	2000-03-13	清原まさ子	流体制御器
US5593852A (en)	1993-12-02	1997-01-14	Heller; Adam	Subcutaneous glucose electrode
US5773270A (en) *	1991-03-12	1998-06-30	Chiron Diagnostics Corporation	Three-layered membrane for use in an electrochemical sensor system
WO1993001221A1 (en)	1991-07-05	1993-01-21	Biocompatibles Limited	Polymeric surface coatings
US5168104A (en)	1991-09-13	1992-12-01	Chembiomed, Ltd.	Macroporous particles as biocompatible chromatographic supports
US5322063A (en)	1991-10-04	1994-06-21	Eli Lilly And Company	Hydrophilic polyurethane membranes for electrochemical glucose sensors
EP0562370B1 (de)	1992-03-23	1997-11-26	Siemens Aktiengesellschaft	Biosensor
ZA938555B (en)	1992-11-23	1994-08-02	Lilly Co Eli	Technique to improve the performance of electrochemical sensors
US5229172A (en)	1993-01-19	1993-07-20	Medtronic, Inc.	Modification of polymeric surface by graft polymerization
US5308641A (en)	1993-01-19	1994-05-03	Medtronic, Inc.	Biocompatibility of solid surfaces
US5299571A (en)	1993-01-22	1994-04-05	Eli Lilly And Company	Apparatus and method for implantation of sensors
US5433710A (en)	1993-03-16	1995-07-18	Minimed, Inc.	Medication infusion pump with fluoropolymer valve seat
US5328954A (en)	1993-04-16	1994-07-12	Icet, Inc.	Encrusting and bacterial resistant coatings for medical applications
US5390691A (en)	1994-01-27	1995-02-21	Sproule; Ronald	Bleed valve for water supply for camping vehicle
US5391250A (en)	1994-03-15	1995-02-21	Minimed Inc.	Method of fabricating thin film sensors
US5390671A (en)	1994-03-15	1995-02-21	Minimed Inc.	Transcutaneous sensor insertion set
ATE202942T1 (de)	1994-04-15	2001-07-15	Cobe Cardiovascular Inc	Blutverträglicher beschichteter artikel
US5482473A (en)	1994-05-09	1996-01-09	Minimed Inc.	Flex circuit connector
JP4000198B2 (ja) *	1994-10-20	2007-10-31	富士通株式会社	会話型回路設計装置
JP3320226B2 (ja) *	1994-11-30	2002-09-03	富士通株式会社	配線ｃａｄ装置
US5662960A (en)	1995-02-01	1997-09-02	Schneider (Usa) Inc.	Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly (n-vinylpyrrolidone) polymer hydrogel
US5568806A (en)	1995-02-16	1996-10-29	Minimed Inc.	Transcutaneous sensor insertion set
US5702754A (en)	1995-02-22	1997-12-30	Meadox Medicals, Inc.	Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
WO1996029102A1 (en)	1995-03-17	1996-09-26	Regents Of The University Of Minnesota	Biocompatible materials
US5786439A (en)	1996-10-24	1998-07-28	Minimed Inc.	Hydrophilic, swellable coatings for biosensors
US5882494A (en)	1995-03-27	1999-03-16	Minimed, Inc.	Polyurethane/polyurea compositions containing silicone for biosensor membranes
US5620738A (en)	1995-06-07	1997-04-15	Union Carbide Chemicals & Plastics Technology Corporation	Non-reactive lubicious coating process
US5609629A (en)	1995-06-07	1997-03-11	Med Institute, Inc.	Coated implantable medical device
US5607475A (en)	1995-08-22	1997-03-04	Medtronic, Inc.	Biocompatible medical article and method
US5672638A (en)	1995-08-22	1997-09-30	Medtronic, Inc.	Biocompatability for solid surfaces
US5913040A (en)	1995-08-22	1999-06-15	Backweb Ltd.	Method and apparatus for transmitting and displaying information between a remote network and a local computer
US5972199A (en) *	1995-10-11	1999-10-26	E. Heller & Company	Electrochemical analyte sensors using thermostable peroxidase
DE69738556T2 (de) *	1996-01-08	2009-03-26	Fujitsu Ltd., Kawasaki	Interaktiver cad-apparat zum entwerfen des zusammenbaus von logischen schaltungen
US5809242A (en)	1996-04-19	1998-09-15	Juno Online Services, L.P.	Electronic mail system for displaying advertisement at local computer received from remote system while the local computer is off-line the remote system
US5728420A (en)	1996-08-09	1998-03-17	Medtronic, Inc.	Oxidative method for attachment of glycoproteins to surfaces of medical devices
US6013855A (en)	1996-08-06	2000-01-11	United States Surgical	Grafting of biocompatible hydrophilic polymers onto inorganic and metal surfaces
US5804048A (en)	1996-08-15	1998-09-08	Via Medical Corporation	Electrode assembly for assaying glucose
KR0176334B1 (ko)	1996-08-19	1999-04-01	박원훈	내인체 감염성 삽입금속표면의 코팅방법 및 그 치료기술
WO1998008553A1 (en)	1996-08-29	1998-03-05	Medtronic, Inc.	Biocompatibility for solid surfaces
US5855618A (en)	1996-09-13	1999-01-05	Meadox Medicals, Inc.	Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
WO1998013685A1 (en) *	1996-09-26	1998-04-02	Minimed, Inc.	Silicon-containing biocompatible membranes
WO1998019627A1 (en)	1996-11-01	1998-05-14	Minimed Inc.	Medication infusion pump with protein stabilized surface coating
US5964993A (en)	1996-12-19	1999-10-12	Implanted Biosystems Inc.	Glucose sensor
US5858186A (en)	1996-12-20	1999-01-12	The Regents Of The University Of California	Urea biosensor for hemodialysis monitoring
CA2278709A1 (en)	1997-01-27	1998-08-13	Benjamin Slotznick	System for delivering and displaying primary and secondary information
US6558351B1 (en)	1999-06-03	2003-05-06	Medtronic Minimed, Inc.	Closed loop system for controlling insulin infusion
US5954643A (en)	1997-06-09	1999-09-21	Minimid Inc.	Insertion set for a transcutaneous sensor
US6411998B1 (en)	1997-09-08	2002-06-25	International Business Machines Corporation	World wide web internet delay monitor
US5965244A (en)	1997-10-24	1999-10-12	Rexam Graphics Inc.	Printing medium comprised of porous medium
US5880364A (en)	1997-10-31	1999-03-09	Cosense, Inc.	Non-contact ultrasonic micromeasurement system
US5939208A (en)	1997-11-07	1999-08-17	Biomimetics, Inc.	Method for creation of biomimetic surfaces
US6579690B1 (en)	1997-12-05	2003-06-17	Therasense, Inc.	Blood analyte monitoring through subcutaneous measurement
US6134461A (en)	1998-03-04	2000-10-17	E. Heller & Company	Electrochemical analyte
US6103033A (en)	1998-03-04	2000-08-15	Therasense, Inc.	Process for producing an electrochemical biosensor
US6175752B1 (en)	1998-04-30	2001-01-16	Therasense, Inc.	Analyte monitoring device and methods of use
AUPP451898A0 (en) *	1998-07-07	1998-07-30	Technosearch Pty. Limited	Improvements in containers
US6554798B1 (en)	1998-08-18	2003-04-29	Medtronic Minimed, Inc.	External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
EP1130996B1 (de)	1998-11-20	2005-04-13	The University of Connecticut	Generisch integriete implantierbare potentiostat fernmessanordnung für elektrochemische fühler
WO2000050871A1 (en) *	1999-02-26	2000-08-31	Orchid Biosciences, Inc.	Microstructures for use in biological assays and reactions
US6475750B1 (en)	1999-05-11	2002-11-05	M-Biotech, Inc.	Glucose biosensor
US6368274B1 (en)	1999-07-01	2002-04-09	Medtronic Minimed, Inc.	Reusable analyte sensor site and method of using the same
US6413393B1 (en)	1999-07-07	2002-07-02	Minimed, Inc.	Sensor including UV-absorbing polymer and method of manufacture
JP3405405B2 (ja) *	1999-07-29	2003-05-12	日本電気株式会社	制限透過膜及び制限透過膜の製造方法、並びに化学センサ及び化学センサの製造方法
EP1253852B1 (de)	2000-02-10	2007-09-19	Medtronic MiniMed, Inc.	Analytensensor
US6340421B1 (en)	2000-05-16	2002-01-22	Minimed Inc.	Microelectrogravimetric method for plating a biosensor
JP2002108960A (ja) *	2000-10-03	2002-04-12	Fujitsu Ltd	配置・配線処理システム
US6642015B2 (en)	2000-12-29	2003-11-04	Minimed Inc.	Hydrophilic polymeric material for coating biosensors
DE60236429D1 (en)	2001-05-30	2010-07-01	I Sens Inc	Biosensor
EP1345057A3 (de)	2002-03-16	2004-08-04	Nexans	Verfahren zur Herstellung eines optischen Kabels
ITMI20020729A1 (it)	2002-04-08	2003-10-08	Resindion S R L	Supporti per l'immobilizzazione covalente di enzimi
US6889828B2 (en) *	2002-07-10	2005-05-10	Denton C. Pursely	Pocket caddy for carrying golf items
EP1418428A1 (de)	2002-11-07	2004-05-12	GenOdyssee	Verfahren zur Bereitstellung von natürlichen therapeutischen Agenzien mit hohem therapeutischen Index
US7162289B2 (en) *	2002-09-27	2007-01-09	Medtronic Minimed, Inc.	Method and apparatus for enhancing the integrity of an implantable sensor device
US20040074785A1 (en)	2002-10-18	2004-04-22	Holker James D.	Analyte sensors and methods for making them
US20050272989A1 (en)	2004-06-04	2005-12-08	Medtronic Minimed, Inc.	Analyte sensors and methods for making and using them
WO2005012873A2 (en) *	2003-07-25	2005-02-10	Dexcom, Inc.	Electrode systems for electrochemical sensors
US20050090607A1 (en)	2003-10-28	2005-04-28	Dexcom, Inc.	Silicone composition for biocompatible membrane
US7637868B2 (en) *	2004-01-12	2009-12-29	Dexcom, Inc.	Composite material for implantable device
WO2006127694A2 (en)	2004-07-13	2006-11-30	Dexcom, Inc.	Analyte sensor
US7468033B2 (en)	2004-09-08	2008-12-23	Medtronic Minimed, Inc.	Blood contacting sensor
US7350175B2 (en) *	2004-09-29	2008-03-25	Matsushita Electric Industrial Co., Ltd.	Circuit board design system, design data analysis method and recording medium with analysis program recorded thereon
US8060174B2 (en) *	2005-04-15	2011-11-15	Dexcom, Inc.	Analyte sensing biointerface
DE102007021561A1 (de) *	2007-05-08	2009-01-15	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Entwurfswerkzeug für Art und Form einer Schaltungsrealisierung
JP2009238130A (ja) *	2008-03-28	2009-10-15	Fujitsu Ltd	プリント基板設計装置およびプリント基板設計方法
CN102054086A (zh) *	2009-10-29	2011-05-11	鸿富锦精密工业（深圳）有限公司	印刷电路板布线系统及错误提示信息管理方法

2005
- 2005-12-13 US US11/301,512 patent/US7813780B2/en active Active
2006
- 2006-12-12 DE DE602006015357T patent/DE602006015357D1/de active Active
- 2006-12-12 EP EP06845231A patent/EP1969359B1/de active Active
- 2006-12-12 WO PCT/US2006/047271 patent/WO2007070486A2/en not_active Ceased
- 2006-12-12 DK DK06845231.7T patent/DK1969359T3/da active
- 2006-12-12 CA CA002632992A patent/CA2632992A1/en not_active Abandoned
- 2006-12-12 AT AT06845231T patent/ATE473433T1/de not_active IP Right Cessation
- 2006-12-12 JP JP2008545720A patent/JP5052525B2/ja not_active Expired - Fee Related
2010
- 2010-05-20 US US12/784,220 patent/US9163273B2/en active Active
- 2010-05-20 US US12/784,233 patent/US20100279377A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20070135698A1 (en)	2007-06-14
JP2009519106A (ja)	2009-05-14
US7813780B2 (en)	2010-10-12
WO2007070486A2 (en)	2007-06-21
ATE473433T1 (de)	2010-07-15
WO2007070486A3 (en)	2007-11-29
JP5052525B2 (ja)	2012-10-17
US20100279377A1 (en)	2010-11-04
US9163273B2 (en)	2015-10-20
WO2007070486A8 (en)	2007-09-20
DK1969359T3 (da)	2010-10-18
EP1969359B1 (de)	2010-07-07
EP1969359A2 (de)	2008-09-17
DE602006015357D1 (de)	2010-08-19
US20100280347A1 (en)	2010-11-04

Legal Events

Date	Code	Title	Description
2011-09-15	EEER	Examination request
2018-01-23	FZDE	Discontinued	Effective date: 20171212

Publication	Publication Date	Title
US9163273B2 (en)	2015-10-20	Biosensors and methods for making and using them
US9541519B2 (en)	2017-01-10	Amperometric sensor electrodes
CA2658607C (en)	2016-12-13	Analyte sensors and methods for making and using them
CA2567899C (en)	2014-07-15	Analyte sensors and methods for making and using them
CA2774778C (en)	2018-06-19	Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
CN109312383B (zh)	2022-05-27	用于连续葡萄糖传感器的原位化学堆栈
WO2001069222A2 (en)	2001-09-20	Implantable analyte sensor
JP2003526491A (ja)	2003-09-09	埋込型アナライトセンサー
CN102387746A (zh)	2012-03-21	分析物传感器和制作方法
US20220047193A1 (en)	2022-02-17	Interference rejection membranes comprising crosslinked poly(vinyl alcohol) matrices for implantable glucose sensors
US20230240566A1 (en)	2023-08-03	Structures for sensor interference rejection